A clinical trial to study the effect of the drug SANGU CHUNNAM in patients having Azhal thalai Nokkadu (Sinusitis)
- Conditions
- AZHAL THALAI NOOKADU (SINUSITIS)
- Registration Number
- CTRI/2018/03/012379
- Lead Sponsor
- Government Siddha Medical College
- Brief Summary
This is a single Non randomized open clinical trial to study the safety and efficacy of siddha trial drug Sangu Chunnam. The trial drug is given 130 mgs twice a day for 48 days. Clinical trial is conducted after conducting Preclinical toxicity study. The trial drug Sangu Chunnam is mentioned in Anuboga Vaidhiya Navaneetham - part I. During the trial all the study related data will be recorded and documented. After the completion of trial all the data will be analysed statistically.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- All
- Target Recruitment
- 40
Age between 16 to 60 years Both male and female Nasal congestion Running Nose Headache Heaviness of Head Pain and Tenderness over at PNS area Recurrent Sneezing Patients with positive x-ray findings.
- Age factor.
- below 16 and above 60 years Pregnancy Lactation Diabetes Mellitus Vasomotor Rhinitis Migraine Otitis Media Malignancy of PNS.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Outcome is estimated by scoring the clinical symptoms and investigations before and after treatment 48 days
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Aringar Anna Government Hospital of Indian Medicine
🇮🇳Chennai, TAMIL NADU, India
Aringar Anna Government Hospital of Indian Medicine🇮🇳Chennai, TAMIL NADU, IndiaDr Indumathy VPrincipal investigator9566536378illavarasi.indu@gmail.com